Cargando…

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy

BACKGROUND: While large-scale cancer genomic projects are comprehensively characterizing the mutational spectrum of various cancers, so far little attention has been devoted to either define the antigenicity of these mutations or to characterize the immune responses they elicit. Here we present a st...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelova, Mihaela, Charoentong, Pornpimol, Hackl, Hubert, Fischer, Maria L, Snajder, Rene, Krogsdam, Anne M, Waldner, Maximilian J, Bindea, Gabriela, Mlecnik, Bernhard, Galon, Jerome, Trajanoski, Zlatko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377852/
https://www.ncbi.nlm.nih.gov/pubmed/25853550
http://dx.doi.org/10.1186/s13059-015-0620-6
_version_ 1782363971260514304
author Angelova, Mihaela
Charoentong, Pornpimol
Hackl, Hubert
Fischer, Maria L
Snajder, Rene
Krogsdam, Anne M
Waldner, Maximilian J
Bindea, Gabriela
Mlecnik, Bernhard
Galon, Jerome
Trajanoski, Zlatko
author_facet Angelova, Mihaela
Charoentong, Pornpimol
Hackl, Hubert
Fischer, Maria L
Snajder, Rene
Krogsdam, Anne M
Waldner, Maximilian J
Bindea, Gabriela
Mlecnik, Bernhard
Galon, Jerome
Trajanoski, Zlatko
author_sort Angelova, Mihaela
collection PubMed
description BACKGROUND: While large-scale cancer genomic projects are comprehensively characterizing the mutational spectrum of various cancers, so far little attention has been devoted to either define the antigenicity of these mutations or to characterize the immune responses they elicit. Here we present a strategy to characterize the immunophenotypes and the antigen-ome of human colorectal cancer. RESULTS: We apply our strategy to a large colorectal cancer cohort (n = 598) and show that subpopulations of tumor-infiltrating lymphocytes are associated with distinct molecular phenotypes. The characterization of the antigenome shows that a large number of cancer-germline antigens are expressed in all patients. In contrast, neo-antigens are rarely shared between patients, indicating that cancer vaccination requires individualized strategy. Analysis of the genetic basis of the tumors reveals distinct tumor escape mechanisms for the patient subgroups. Hypermutated tumors are depleted of immunosuppressive cells and show upregulation of immunoinhibitory molecules. Non-hypermutated tumors are enriched with immunosuppressive cells, and the expression of immunoinhibitors and MHC molecules is downregulated. Reconstruction of the interaction network of tumor-infiltrating lymphocytes and immunomodulatory molecules followed by a validation with 11 independent cohorts (n = 1,945) identifies BCMA as a novel druggable target. Finally, linear regression modeling identifies major determinants of tumor immunogenicity, which include well-characterized modulators as well as a novel candidate, CCR8, which is then tested in an orthologous immunodeficient mouse model. CONCLUSIONS: The immunophenotypes of the tumors and the cancer antigenome remain widely unexplored, and our findings represent a step toward the development of personalized cancer immunotherapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0620-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4377852
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43778522015-03-31 Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy Angelova, Mihaela Charoentong, Pornpimol Hackl, Hubert Fischer, Maria L Snajder, Rene Krogsdam, Anne M Waldner, Maximilian J Bindea, Gabriela Mlecnik, Bernhard Galon, Jerome Trajanoski, Zlatko Genome Biol Research BACKGROUND: While large-scale cancer genomic projects are comprehensively characterizing the mutational spectrum of various cancers, so far little attention has been devoted to either define the antigenicity of these mutations or to characterize the immune responses they elicit. Here we present a strategy to characterize the immunophenotypes and the antigen-ome of human colorectal cancer. RESULTS: We apply our strategy to a large colorectal cancer cohort (n = 598) and show that subpopulations of tumor-infiltrating lymphocytes are associated with distinct molecular phenotypes. The characterization of the antigenome shows that a large number of cancer-germline antigens are expressed in all patients. In contrast, neo-antigens are rarely shared between patients, indicating that cancer vaccination requires individualized strategy. Analysis of the genetic basis of the tumors reveals distinct tumor escape mechanisms for the patient subgroups. Hypermutated tumors are depleted of immunosuppressive cells and show upregulation of immunoinhibitory molecules. Non-hypermutated tumors are enriched with immunosuppressive cells, and the expression of immunoinhibitors and MHC molecules is downregulated. Reconstruction of the interaction network of tumor-infiltrating lymphocytes and immunomodulatory molecules followed by a validation with 11 independent cohorts (n = 1,945) identifies BCMA as a novel druggable target. Finally, linear regression modeling identifies major determinants of tumor immunogenicity, which include well-characterized modulators as well as a novel candidate, CCR8, which is then tested in an orthologous immunodeficient mouse model. CONCLUSIONS: The immunophenotypes of the tumors and the cancer antigenome remain widely unexplored, and our findings represent a step toward the development of personalized cancer immunotherapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0620-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-31 2015 /pmc/articles/PMC4377852/ /pubmed/25853550 http://dx.doi.org/10.1186/s13059-015-0620-6 Text en © Angelova et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Angelova, Mihaela
Charoentong, Pornpimol
Hackl, Hubert
Fischer, Maria L
Snajder, Rene
Krogsdam, Anne M
Waldner, Maximilian J
Bindea, Gabriela
Mlecnik, Bernhard
Galon, Jerome
Trajanoski, Zlatko
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
title Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
title_full Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
title_fullStr Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
title_full_unstemmed Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
title_short Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
title_sort characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377852/
https://www.ncbi.nlm.nih.gov/pubmed/25853550
http://dx.doi.org/10.1186/s13059-015-0620-6
work_keys_str_mv AT angelovamihaela characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT charoentongpornpimol characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT hacklhubert characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT fischermarial characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT snajderrene characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT krogsdamannem characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT waldnermaximilianj characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT bindeagabriela characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT mlecnikbernhard characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT galonjerome characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy
AT trajanoskizlatko characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy